Stroke in a young adult receiving intravenous immunoglobulin therapy for immune thrombocytopenic purpura
Intravenous immunoglobulin (IVIG) is increasingly being used in wide variety of auto-immune and inflammatory disorders. FDA has approved the use of IVIG in primary and secondary immune-deficiencies like Chronic Lymphoid leukemia, HIV infection, prevention of GVHD in bone marrow transplantation, ITP,...
Main Author: | Javed Iqbal Wani |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Journal of Applied Hematology |
Subjects: | |
Online Access: | http://www.jahjournal.org/article.asp?issn=1658-5127;year=2016;volume=7;issue=1;spage=35;epage=37;aulast=Wani |
Similar Items
-
A serious thrombotic event in a patient with immune thrombocytopenia requiring intravenous immunoglobulin: a case report
by: Tarinee Rungjirajittranon, et al.
Published: (2019-01-01) -
Aseptic meningitis after intravenous immunoglobulin (IVIG) infusion in children with immune thrombocytopenic purpura (ITP)
by: A Tamaddoni, et al.
Published: (2001-04-01) -
Comparison of Intravenous Immunoglobulin (IVIG) and Intravenous anti-D for Treatment of Acute Idiopathic Thrombocytopenic Purpura
by: Zahra Farahmandinia, et al.
Published: (2010-10-01) -
Comparison of Intravenous Immunoglobulin (IVIG) and Intravenous anti-D for Treatment of Acute Idiopathic Thrombocytopenic Purpura
by: Zahra Farahmandinia, et al.
Published: (2010-12-01) -
LIVEdoid vasculopathy – benefit of intravenous immunoglobulin in a refractory case
by: Stefan Cristian Dinescu, et al.
Published: (2021-03-01)